Toggle navigation
Home
Search
Services
Blog
Contact
About
Prioritize, Review Marketed Pediatric Drugs
Johnson, Keith
U.S. Pharmacopeia, Rockville, MD, United States
Search 174 grants from Keith Johnson
Search grants from U.S. Pharmacopeia
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Epidemiology of Bone Loss in African Men
Patient Oriented Research &Mentoring in liver diseases
Chemoreception and Signal Amplification
Src Tyrosine Kinases in Hematopoietic Cell Development
Neuromuscular Plasticity After Spinal Cord Injury
Recently added grants:
Development of Long non-coding RNA-directed Target Therapy for Triple-Negative Breast Cancer
Administrative Core
Mechanisms of treatment failure in chimeric antigen receptor T cell therapy
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer
Employing CRISPR inactivation screening and in vivo models towards improving treatments for SCLC
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research and Development Contracts (N01)
Project #
N01HD093305-001
Application #
6344575
Study Section
Project Start
1999-09-30
Project End
2004-09-29
Budget Start
2000-08-08
Budget End
2001-09-29
Support Year
Fiscal Year
2000
Total Cost
$132,551
Indirect Cost
Institution
Name
U.S. Pharmacopeia
Department
Type
DUNS #
City
Rockville
State
MD
Country
United States
Zip Code
20852
Related projects
NIH 2000
N01 HD
Prioritize, Review Marketed Pediatric Drugs
Johnson, Keith / U.S. Pharmacopeia
$132,551
NIH 1999
N01 HD
Prioritize, Review Marketed Pediatric Drugs
Johnson, Keith / U.S. Pharmacopeia
Comments
Be the first to comment on Keith Johnson's grant
